ORAL VANCOMYCIN AS AN EFFECTIVE MONOTHERAPY FOR THE TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS

被引：0
|
作者：
Tsay, Cynthia
Lemos, Leta
Scudiere, Jennifer R.
Cox, Kenneth
Davies, Yinka
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1490
引用
收藏
页码：S1325 / S1325
页数：1
相关论文
共 50 条
  • [31] PAEDIATRIC PRIMARY SCLEROSING CHOLANGITIS-ULCERATIVE COLITIS.AUDIT OF 2 YEAR OUTCOME WITH ORAL VANCOMYCIN TREATMENT
    Balouch, Fariha
    Burgess, Christopher J.
    Tan, Li-Zsa
    Reilly, Claire
    Clark, Julia
    Lewindon, Peter J.
    GASTROENTEROLOGY, 2021, 160 (06) : S44 - S44
  • [32] Clinical Outcomes of Oral Vancomycin Therapy for Children with Primary Sclerosing Cholangitis in the Pediatric PSC Consortium
    Deneau, Mark
    Abdou, Reham
    Amin, Mansi
    Amir, Achiya Z.
    Auth, Marcus
    Broderick, Annemarie
    Chan, Albert
    DiGuglielmo, Matthew
    El-Matary, Wael
    El-Youssef, Mounif
    Ferrari, Federica
    Furuya, Katryn
    Gottrand, Frederic
    Gupta, Nitika Arora
    Homan, Matjaz
    Jensen, M. Kyle
    Kamath, Binita M.
    Kim, Kyung Mo
    Kolho, Kaija-Leena
    Konidari, Anastasia
    Koot, Bart
    Iorio, Raffaele
    Lin, Henry C.
    Mack, Cara Lynn
    Martinez, Mercedes
    Mohan, Parvathi
    Palle, Sirish Kumar
    Papadopoulou, Alexandra
    Perito, Emily J. Rothbaum
    Ricciuto, Amanda
    Saubermann, Lawrence
    Sathya, Pushpa
    Shah, Uzma
    Shteyer, Eyal
    Smolka, Vratislav
    Tanaka, Atsushi
    Valentino, Pamela L.
    Varier, Raghu
    Venkat, Veena L.
    Vitola, Bernadette
    Vos, Miriam B.
    Woynarowski, Marek
    Yap, Jason Y. K.
    Miloh, Tamir
    HEPATOLOGY, 2018, 68 : 114A - 115A
  • [33] The Effectiveness of Oral Vancomycin on Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis: A Systematic Review
    Arbabzada, Naik
    Dennett, Liz
    Meng, Guanmin
    Peerani, Farhad
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [34] An Open Label Pilot Trial of Oral Vancomycin in Primary Sclerosing Cholangitis - Results of the VIP Trial
    Pratt, Daniel
    Agarwal, Sheela
    Saini, Sanjay
    Misdraji, Joseph
    Korzenik, Joshua R.
    GASTROENTEROLOGY, 2011, 140 (05) : S907 - S907
  • [35] How frequent are vancomycin-resistant enterococci in patients with primary sclerosing cholangitis and ulcerative colitis treated with oral vancomycin?
    Shah, Ayesha
    Pakneeshan, Sahar
    Jones, Michael P.
    Koloski, Natasha
    Callaghan, Gavin
    Morrison, Mark
    Holtmann, Gerald
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2022, 41 (05) : 519 - 524
  • [36] How frequent are vancomycin-resistant enterococci in patients with primary sclerosing cholangitis and ulcerative colitis treated with oral vancomycin?
    Ayesha Shah
    Sahar Pakneeshan
    Michael P Jones
    Natasha Koloski
    Gavin Callaghan
    Mark Morrison
    Gerald Holtmann
    Indian Journal of Gastroenterology, 2022, 41 : 519 - 524
  • [37] Standard treatment for primary sclerosing cholangitis and overlap autoimmune hepatitis/primary sclerosing cholangitis
    Schrumpf, E
    Boberg, KM
    Autoimmune Liver Disease, 2005, 142 : 203 - 207
  • [38] Oral nicotine in the treatment of primary sclerosing cholangitis: A pilot study.
    Angulo, P
    Bharucha, AE
    Jorgensen, RA
    Sandborn, WJ
    LaRusso, NF
    Lindor, KD
    GASTROENTEROLOGY, 1998, 114 (04) : A1204 - A1204
  • [39] Reply: Insurance should cover vancomycin for primary sclerosing cholangitis
    Bowlus, Christopher L.
    Arrive, Lionel
    Bergquist, Annika
    Deneau, Mark
    Forman, Lisa
    Ilyas, Sumera I.
    Lunsford, Keri E.
    Martinez, Mercedes
    Sapisochin, Gonzalo
    Shroff, Rachna
    Tabibian, James H.
    Assis, David N.
    HEPATOLOGY, 2023, 77 (06) : E176 - E177
  • [40] Treatment options for primary sclerosing cholangitis
    Sinakos, Emmanouil
    Lindor, Keith
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (04) : 473 - 488
12345